Clinical trial
Risperidone LA Heathcare Resource Study
NCT00272597 · University of British Columbia, Other · Completed
Key facts
| NCT number | NCT00272597 |
|---|---|
| Title | Risperidone LA Heathcare Resource Study |
| Official title | Risperidone Long Acting: A Healthcare Resource Utilization Pilot Study |
| Lead sponsor | University of British Columbia, Other |
| Collaborators | Riverview Hospital |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Psychosis, Schizophrenia |
| Intervention type | Drug |
| Interventions | Risperidone |
| Enrollment | 30 |
| Start date | Sep 1, 2005 |
| Primary completion | Oct 1, 2010 |
| Completion | Oct 1, 2010 |
| First posted | Jan 6, 2006 |
| Last update posted | Nov 29, 2017 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: